GSK shares surge as US judge dismisses Zantac cancer claims

GSK shares surge as US judge dismisses Zantac cancer claims

Source: 
The Guardian, UK
News Tags: 
snippet: 

Shares in drug firms GlaxoSmithKline and Sanofi surged after a US judge dismissed thousands of lawsuits claiming that the heartburn drug Zantac caused cancer.

GSK’s shares jumped as much as 14% in early trading, while Sanofi’s stock jumped nearly 6% in mid-morning trading.